Saudi Arabia Diabetes Market Report and Forecast

590 views

Published on

Published in: Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
590
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
18
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Saudi Arabia Diabetes Market Report and Forecast

  1. 1. About IMARCFor more than 5 years, the International Market Analysis Research and Consulting Group hasbeen a leading advisor on management strategy and market research worldwide. We partnerwith clients in all sectors and regions to identify their highest-value opportunities, address theirmost critical challenges, and transform their businesses.IMARCs information products include major market, scientific, economic and technologicaldevelopments for business leaders in pharmaceutical, industrial, and high technologyorganizations. Market forecasts and industry analysis for biotechnology, advanced materials,pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processingmethods are at the top of the companys expertise.IMARC’s tailored approach combines unfathomable insight into the dynamics of companies andmarkets with close cooperation at all levels of the client organization. This ensures that ourclients achieve unmatchable competitive advantage, build more proficient organizations, andsecure lasting results.imarc© 2
  2. 2. About The ReportIMARC’s new report “Saudi Arabia Diabetes Market Report & Forecast 2011-2016” providesan analytical and statistical insight into the Saudi Arabian diabetes market. The reportprovides both current and future trends in the prevalence, demographical breakup andregional breakup of diabetes in Saudi Arabia. The report has segmented the Saudi Arabiandiabetes market into two segments – Insulin and the Oral Antidiabetics market. For each ofthe aforementioned categories, the report provides historical and future market sales of keyclasses, key companies, key drugs and key molecules.The research study serves as an exceptional tool to understand the market trends,therapeutic structure, competitive structure and the outlook of the Saudi Arabian diabetesmarket till 2016. This report can serve as an excellent guide for investors, researchers,consultants, marketing strategists and all those who are planning to foray into the SaudiArabian diabetes market in some form or the other.Key Questions Answered in this Report: What is the size and demographical breakup of the diabetes population in Saudi Arabia? How has the diabetes market behaved since 2005 and what are the expected trends till 2016? What has been the historical performance of the Saudi Arabian Insulin market during 2005- 2010 and its outlook till 2016? What has been the performance of top classes, top players, top molecules and top drugs in the Insulin market during 2005-2010? What has been the historical performance of the Oral Antidiabetics market during 2005- 2010 and its outlook till 2016? What has been the performance of top classes, top players, top molecules and top drugs in the Oral Antidiabetics market during 2005-2010?Why should you buy this report? Gain a deeper understanding on the epidemiology of diabetes in Saudi Arabia and identify your potential patient pool.imarc© 3
  3. 3. Analyze the historical, current and future trends in the Insulin and Oral Antidiabetics market to identify potential classes, drugs, partners and competitors for market entry and expansion plans. Develop Investment strategies by identifying companies that have been the biggest winners and losers in the Saudi Arabian Insulin and Oral Antidiabetics market. Gain an insight into future market events such as new product launches.Classes Covered:Fast acting Insulins, Long acting Insulins, Intermediate and Fast acting Insulins, Intermediateacting Insulins, Biguanides, Glinides, Sulphonylureas, Glitazones, DPP-IV Inhibitors, Glp-1Agonists, Alpha-Glucosidase Inhibitors, DPP-IV Inhibitor and Biguanide Combinations,Glitazone and Sulphonylurea Combinations, DPP-IV Inhibitor and Biguanide AntidiabeticCombinations, SGLT Inhibitors, SGLT Inhibitor and Biguanide combinations and all other OralAntidiabetic classes.Information Sources:Information has been sourced from both primary and secondary sources: Primary sources include industry surveys and face to face/telephonic interviews with physicians and industry experts. Secondary sources include proprietary databases and search engines. These sources include company websites and reports, books, trade journals, magazines, white papers, Industry Portals, government sources and access to more than 4000 paid databases.Forecasting Methodology:IMARC generates its product and market forecasts utilizing its extensive database ofmacroeconomic and sector specific data. The initial baseline forecast is generated with themost recent market data. After an initial baseline forecast, all future macroeconomic andsector specific events and assumptions are taken into account to generate the final forecast.imarc© 4
  4. 4. Table of Contents1 Research Methodology & Market Definitions ..................................................................................... 82 Executive Summary ............................................................................................................................. 103 Epidemiology ....................................................................................................................................... 13 3.1 Total Diabetes Patients .................................................................................................................. 13 3.2 Patients by Gender ......................................................................................................................... 14 3.3 Patients by Age Group ................................................................................................................... 15 3.4 Patients by Region ......................................................................................................................... 164 Market Dynamics ................................................................................................................................. 17 4.1 Diabetes Market .............................................................................................................................. 17 4.1.1 Current Trends (2005–2010)....................................................................................................... 17 4.1.2 Market Forecast (2011-2016)...................................................................................................... 18 4.2 Insulin Market .................................................................................................................................. 19 4.2.1 Current Trends (2005-2010) ....................................................................................................... 19 4.2.1.1 Market by Class....................................................................................................................... 20 4.2.1.2 Market by Molecule ................................................................................................................. 20 4.2.1.3 Top Players ............................................................................................................................. 22 4.2.1.4 Top Drugs ................................................................................................................................ 23 4.2.2 Forecast (2011-2016) .................................................................................................................. 25 4.3 Oral Antidiabetics Market .............................................................................................................. 26 4.3.1 Current Trends (2005-2010) ....................................................................................................... 26 4.3.1.1 Market by Class....................................................................................................................... 28 4.3.1.2 Top Players ............................................................................................................................. 30 4.3.1.3 Top Drugs ................................................................................................................................ 31 4.3.2 Forecast (2011-2016) .................................................................................................................. 33imarc© 5
  5. 5. List of FiguresFigure 2-1: Saudi Arabia: Number of Diabetes Patients* (in 000’s), 2010, 2015, 2020, 2025 & 2030 ......................... 13Figure 2-2: Saudi Arabia: Breakup of Diabetes Patients* by Gender (in 000’s), 2010, 2015, 2020, 2025 & 2030 ....... 14Figure 2-3: Saudi Arabia: Breakup of Diabetes Patients* by Gender (in %) 2010, 2015, 2020, 2025 & 2030 .............. 14Figure 2-4: Saudi Arabia: Breakup of Diabetes Patients* by Age Group (in 000’s), 2010, 2015, 2020, 2025 & 2030 .. 15Figure 2-5: Saudi Arabia: Breakup of Diabetes Patients* by Age Group (in %) 2010, 2015, 2020, 2025 & 2030 ........ 15Figure 2-2: Saudi Arabia: Breakup of Diabetes Patients* by Region (in 000’s), 2010, 2015, 2020, 2025 & 2030 ........ 16Figure 2-6: Saudi Arabia: Breakup of Number of Patients* by Region, (%) 2010, 2015 & 2020 .................................. 16Figure 3-1: Saudi Arabia: Diabetes Market (in Million US$), 2005-2010 ...................................................................... 17Figure 3-2: Saudi Arabia: Diabetes Market: Breakup of Insulin and Oral Antidiabetics (in %), 2005-2010 ................. 17Figure 3-3: Saudi Arabia: Diabetes Market Forecast (in Million US$), 2011-2016 ....................................................... 18Figure 3-4: Saudi Arabia: Diabetes Market: Breakup of Insulin and Oral Antidiabetics (in %), 2011-2016 .................. 18Figure 3-5: Saudi Arabia: Insulin Market (in Million US$), 2005-2010 .......................................................................... 19Figure 3-6: Saudi Arabia: Breakup of Insulin Market by Class (in %), 2005-2010 ........................................................ 20Figure 3-7: Saudi Arabia: Insulin Market: Share by Molecules (in %), 2005-2010 ...................................................... 21Figure 3-8: Saudi Arabia: Insulin Market: Share of Key Players (in %), 2005-2010 .................................................... 22Figure 3-9: Saudi Arabia: Insulin Market: Share of Key Drugs (in %), 2005-2010 ....................................................... 24Figure 3-10: Saudi Arabia: Insulin Market Forecast (in Million US$), 2011-2016 ......................................................... 25Figure 3-11: Saudi Arabia: Oral Antidiabetics Market, (in Million US$), 2005-2010 ..................................................... 27Figure 3-12: Saudi Arabia: Oral Antidiabetics Market: Share by Class (in %), 2005-2010 ........................................... 29Figure 3-13: Saudi Arabia: Oral Antidiabetics Market: Share of Key Players (in %), 2005-2010................................. 31Figure 3-14: Saudi Arabia: Oral Antidiabetics Market: Share of Key Drugs (%), 2005-2010........................................ 32Figure 3-15: Saudi Arabia: Oral Antidiabetics Market Forecast (in Million US$), 2011-2016 ....................................... 34Figure 3-16: Saudi Arabia: Oral Antidiabetics Market: Share by Class Forecast (in %), .............................................. 35imarc© 6
  6. 6. List of TablesTable 1-1: Saudi Arabia: Oral Antidiabetics & Insulin Definitions ...................................................................................8Table 3-1: Saudi Arabia: Breakup of Insulin Market by Class (in 000 US$), 2005-2010 .............................................. 20Table 3-2: Saudi Arabia: Insulin Market: Sales by Molecule (in 000 US$), 2005-2010 ............................................... 21Table 3-3: Saudi Arabia: Insulin Market: Share of Key Players (in 000 US$), 2005-2010........................................... 22Table 3-4: Saudi Arabia: Insulin Market, Sales of Top Drugs (in 000 US$), 2005-2010............................................... 23Table 3-5: Saudi Arabia: Oral Antidiabetics Market: Sales by Class (in 000 US$), 2005-2010 .................................... 28Table 3-6: Saudi Arabia: Oral Antidiabetics Market: Sales of Key Players (in 000 US$), ............................................ 30Table 3-7: Saudi Arabia: Oral Antidiabetics Market, Sales of Top Drugs (in 000 US$), 2005-2010 ............................. 32Table 3-8: Saudi Arabia: Oral Antidiabetics Market, New Drug Launches (2011-2016) ............................................... 33Table 3-9: Saudi Arabia: Oral Antidiabetics Market by Class Forecast, (in 000 US$), 2010, 2013 & 2016 .................. 35imarc© 7
  7. 7. Prices and Order Information Electronic Access Electronic Access CD-ROM Mail Delivery Hard Copy Mail Delivery(Single User License) (Multi User License) (Single User License) (Single User License) US$ 750 US$ 1300 US$ 900 US$ 900 For more information visit: http://www.imarcgroup.com/saudi-arabia-diabetes-market-report-forecast- 2011-2016/ To buy the complete report or to get a free sample: Call: +91-120-425-6531 (Asia), +44-844-774-9660 (Europe), +1-631-791-1145 (America) Email:sales@imarcgroup.com

×